Narrow search
Showing 1 - 10 of 14,275
Cover Image
The stock market valuation of research and development expenditures
Chan, Louis K. C.; Lakonishok, Josef; Sougiannis, Theodore - 2009
Persistent link: https://www.econbiz.de/10003851699
Cover Image
Essays in monetary policy and comprehensive income accounting : inferring time-varying central bank preferences and the value of ideas
Beechey, Meredith Jane - 2005
Persistent link: https://www.econbiz.de/10003380174
Cover Image
Risk and return on technology stocks and the aggregate stock market
Khatchatrian, Varoujan - 2004
Persistent link: https://www.econbiz.de/10003384712
Cover Image
The stock market valuation of research and development expenditures
Chan, Louis K. C.; Lakonishok, Josef; Sougiannis, Theodore - In: The journal of finance : the journal of the American … 56 (2001) 6, pp. 2431-2456
Persistent link: https://www.econbiz.de/10001631761
Cover Image
The stock market valuation of research and development expenditures
Chan, Louis K. C.; Lakonishok, Josef; Sougiannis, Theodore - 1999
Persistent link: https://www.econbiz.de/10001399757
Cover Image
The stock market valuation of research and development expenditures
Chan, Louis K. C.; Lakonishok, Josef; Sougiannis, Theodore - In: Intangible assets : values, measures, and risks, (pp. 387-414). 2003
Persistent link: https://www.econbiz.de/10001753148
Cover Image
The Stock Market Valuation of Research and Development Expenditures
Chan, Louis K.C. - 1999
We examine whether stock prices fully reflect the value of firms' intangible assets, focusing on research and development (R&D). Since intangible assets are not reported on financial statements under current U.S. accounting standards and R&D spending is expensed, the valuation problem may be...
Persistent link: https://www.econbiz.de/10012471566
Cover Image
The Stock Market Valuation of Research and Development Expenditures
Chan, Louis K.C; Lakonishok, Josef; Sougiannis, Theodore - 2021
We examine whether stock prices fully reflect the value of firms' intangible assets, focusing on research and development (R&D). Since intangible assets are not reported on financial statements under current U.S. accounting standards and R&D spending is expensed, the valuation problem may be...
Persistent link: https://www.econbiz.de/10013211643
Cover Image
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina; Gurdgiev, Constantin - In: Applied economics letters 23 (2016) 4/6, pp. 278-283
Persistent link: https://www.econbiz.de/10011430453
Cover Image
Patents and R&D Expenditure Effects on Equity Returns in Pharmaceutical Industry
Feyzrakhmanova, Martina - 2015
on patent six months prior and returns in excess of pharmaceutical equity index. The number of patents granted by USPTO …
Persistent link: https://www.econbiz.de/10013033563